WHAT IS THE PLACE OF CARBOPLATIN IN PEDIATRIC ONCOLOGY

被引：46

作者：

DOZ, F ^{[1
]}

PINKERTON, R ^{[1
]}

机构：

[1] ROYAL MARSDEN HOSP,SUTTON SM2 5PT,SURREY,ENGLAND

来源：

EUROPEAN JOURNAL OF CANCER | 1994年 / 30A卷 / 02期

关键词：

D O I：

10.1016/0959-8049(94)90086-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：194 / 201

页数：8

共 91 条

[1] CARBOPLATIN AND RECURRENT CHILDHOOD BRAIN-TUMORS [J].

ALLEN, JC ;

WALKER, R ;

LUKS, E ;

JENNINGS, M ;

BARFOOT, S ;

TAN, C .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) :459-463

[2]

ANDREWS PA, 1990, CANCER CELL-MON REV, V2, P35

[3]

BACHA DM, 1986, CANCER TREAT REP, V70, P865

[4] RANDOMIZED TRIAL OF ETOPOSIDE AND CISPLATIN VERSUS ETOPOSIDE AND CARBOPLATIN IN PATIENTS WITH GOOD-RISK GERM-CELL TUMORS - A MULTIINSTITUTIONAL STUDY [J].

BAJORIN, DF ;

SAROSDY, MF ;

PFISTER, DG ;

MAZUMDAR, M ;

MOTZER, RJ ;

SCHER, HI ;

GELLER, NL ;

FAIR, WR ;

HERR, H ;

SOGANI, P ;

SHEINFELD, J ;

RUSSO, P ;

VLAMIS, V ;

CAREY, R ;

VOGELZANG, NJ ;

CRAWFORD, ED ;

BOSL, GJ .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :598-606

[5]

BALIS FM, 1989, PRINCIPLES PRACTICE, P178

[6]

BAUM ES, 1981, CANCER TREAT REP, V65, P815

[7] CIRCADIAN TIME-DEPENDENCE OF MURINE TOLERANCE FOR CARBOPLATIN [J].

BOUGHATTAS, NA ;

LEVI, F ;

HECQUET, B ;

LEMAIGRE, G ;

ROULON, A ;

FOURNIER, C ;

REINBERG, A .

TOXICOLOGY AND APPLIED PHARMACOLOGY, 1988, 96 (02) :233-247

[8] NEPHROTOXICITY FOLLOWING CARBOPLATIN USE IN CHILDREN - IS ROUTINE MONITORING OF RENAL-FUNCTION NECESSARY [J].

BRANDT, LJ ;

BROADBENT, V .

MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (01) :31-35

[9] OTOTOXICITY OF HIGH-DOSE CIS-PLATINUM IN CHILDREN [J].

BROCK, P ;

PRITCHARD, J ;

BELLMAN, S ;

PINKERTON, CR .

MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05) :368-369

[10]

BRUGIERES L, 1993, P AM SOC CLIN ONCOL, V12, P426

← 1 2 3 4 5 6 7 8 9 10 →